FDA Approved Eczema with Dupilumab

FDA Approved Dupilumab to Treat Eczema

Dupilumab (Dupixent) was approved by the FDA in 2017 to treat moderate to severe eczema (or atopic dermatitis).

“This medicine has been a game-changer for my patients, many of whom have been suffering most of their lives,” says Dr. George. Approximately 30% of children and 10% of adults suffer from eczema. Before this new treatment option, patients were stuck with messy topical steroids and higher risk systemic medicines to suppress the immune system which worked only moderately well for some or not at all. The skin clearance has been remarkable with Dupixent, giving patients hope that they can finally have relief from itchy, raw, red, cracked skin.

If you believe that you may be suffering from Eczema schedule your appointment today with Dr. Mary Noel George, a board certified dermatologist that can help you find the best treatment for you!

What Our Patients Are Saying

Excellent care from Dr. George and her entire staff. The offices are brand new and beautiful, not to mention clean as can be.

Kathleen
See More Reviews

Request An Appointment

Contact our office at the number below to speak with a member of our team to schedule an appointment.

(314) 344-0004